Rheumatoid Arthritis Therapeutics Market valued at US$ 33,958.4 Mn, Introducing Cost-efficient Drugs Will Boost Market, says Fortune Business Insights
Exhibiting a high prevalence for rheumatoid arthritis, North America is forecast to lead the global “ rheumatoid arthritis therapeutics market ” in a recent report. In a report, titled “RHEUMATOID ARTHRITIS THERAPEUTICS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2018-2025”, Fortune Business Insights identifies numerous factors enabling growth in the market. According to the report, the global rheumatoid arthritis therapeutics market is anticipated to exhibit 4.6% CAGR and reach valuation of US$ 33,958.4 Mn in 2025 from US$ 23,822.5 Mn in 2017. Request a Sample Copy of the Research Report North America to Lead Global Market with Rising Prevalence of Rheumatoid Arthritis The North America market was worth US$ 9,929.6 Mn in 2017. It is expected to show steady rise owing to the rising prevalence of rheumatoid arthritis and increasing awareness about this disorder. Adding to that, governments of North America are investing huge sums for improving the healthcare and medical facilities